Carbon dioxide (CO2) is one of the major greenhouse gas (GHG) emitted by human activities, accounting for more than 80% of the total GHG emissions in the U.S. CO2 traps heat in the atmosphere by absorbing radiation within the infrared range. Excessive CO2 emission contributes to the increasing surface temperature of Earth, which has detrimental impacts on environment, ecosystems and biodiversity. On a smaller scale, high level of carbon dioxide (>1,000 ppm) in residential or commercial buildings, often a result of poor ventilation and/or high human activity, can cause health issues, such as headaches and fatigue. Extremely high concentrations of carbon dioxide can cause nausea, dizziness, and vomiting.
Currently, carbon pollution is primarily mitigated by passive approaches, and the most effective way is the reduction of fossil fuel consumption. This requires changes in behavior, infrastructure upgrades, and significant technological development. More active methods have also been explored, including CO2 capture and sequestration. However, these approaches are mainly suitable for large-scale power plants or industrial processes, due to the technological complexity and cost.
Various studies have estimated the CO2 consumption from green algae ponds, which ranges from 0.07 to 0.21 ton per meter square per year. The CO2 reduction rate is dependent on the surface area of the algal pond, based on how much light energy is absorbed. Algae have high growth rate due to their simple structures and high energy conversion efficiency. Industrial-scale algae production has been practiced for several decades at low cost. However, attempts at low-cost, stable encapsulation of algae in solid constructions have had limited success.
Silk has been used in prior systems to stabilize living animal cells in various applications in order to facilitate cell growth or stabilization. In such systems, the silk constructs act to temporarily stabilize the animal cells for eventual release from the construct. Applications for such constructs have included in vivo and in vitro tissue generation, where the animal cells are removed from the silk construct or the silk construct is degraded away in a subject.
Therefore, there is an unmet need for methods and compositions that allow for algae encapsulation in various commercial applications, in order to facilitate CO2 reduction and oxygen generation.
The present disclosure address the aforementioned drawbacks by providing, in part, bio-compatible hydrogel materials that encapsulate photosynthetic organisms, such as green algae, to ensure viability and functionality. Silk fibroin was discovered to be a suitable base material for the hydrogel articles described herein, which provide a cell-friendly matrix that allows 3D encapsulation of microalgae while maintaining normal cell proliferation and functions. In some aspects, the unique combination of silk fibroin and hydroxypropyl methylcellulose (HPMC) allow for 3D printing and easy fabrication of the articles into various forms. Consequently, the methods, articles and systems of the present disclosure may provide traits that no existing GHG mitigation technologies can offer, including low cost, environmental compatibility, self-sustainability, and long-term functionality without human intervention.
In one aspect, the present disclosure provides a method of making a silk article. The method comprising preparing a silk fibroin solution comprising silk fibroin and microalgae; and introducing the silk fibroin solution into a solvent bath comprising a crosslinking agent.
In another aspect, the present disclosure provides a method of making a silk article. The method comprising preparing a silk fibroin solution comprising silk fibroin, horseradish peroxidase, and hydroxypropyl methylcellulose; and introducing the silk fibroin solution into a solvent bath comprising hydrogen peroxide.
In one aspect, the present disclosure provides a silk article comprising silk fibroin and microalgae, wherein the silk article is configured to allow the microalgae to undergo photosynthesis.
In another aspect, the present disclosure provides a silk article comprising silk fibroin, hydroxypropyl methylcellulose, and horseradish peroxidase.
In one aspect, the present disclosure provides a system for forming a silk article. The system comprising a source of silk fibroin solution, the silk fibroin solution comprising silk fibroin and microalgae; a solvent bath comprising a cross-linking agent; and an injector configured to introduce the silk fibroin solution into the solvent bath.
These and other advantages and features of the present invention will become more apparent from the following detailed description of the preferred aspects of the present invention when viewed in conjunction with the accompanying drawings. In the description, reference is made to the accompanying drawings which form a part hereof, and in which there is shown by way of illustration a preferred embodiment of the invention. Such embodiment does not necessarily represent the full scope of the invention, however, and reference is made therefore to the claims and herein for interpreting the scope of the invention. It should be understood, that the detailed description, while indicating embodiments of the present invention, is given by way of illustration only, not limitation. Various changes and modifications within the scope of the invention will become apparent to those skilled in the art from the detailed description.
The drawings described herein are for illustration purposes only and are not intended to limit the scope of the disclosed embodiments in any way. The drawings described herein are for illustrative purposes only of selected embodiments and not all possible implementations, and are not intended to limit the scope of any of the various embodiments. It is understood that the drawings are not drawn to scale.
Described herein are systems and methods that relate to algal containing structures, such as a silk hydrogel-algal containing structures. The systems and methods presented herein may be used for oxygen replenishment and carbon dioxide reduction in a variety of commercial applications. The present disclosure addresses the issues of carbon dioxide pollution by developing living architectures that allow sustainable, active removal of carbon dioxide from the environment using devices that can function for extended time frames. Living photosynthetic organisms (i.e. Microalgae) may be encapsulated in biocompatible silk hydrogels to ensure long-term viability and photosynthetic activity.
Among other applications, the articles described herein can be fabricated into arbitrary-shaped, multi-scale structures, while also functioning to remove carbon dioxide from the air. Such systems display traits that prior GHG mitigation technologies fail to offer, including low cost, environmental compatibility, self-sustainability, compostability and long-term functions without human intervention. The systems and method of the present disclosure can be utilized for small-scale carbon dioxide removal for indoor environments, or scaled up for industrial-scale carbon dioxide reduction. Microalgae has previously been used in food and various supplements. The articles described herein may be used as part of consumer products that are ingested or applied to the body.
The methods, articles, and systems of the present disclosure offer significant advantages over prior encapsulated algae constructions. For instance, the present disclosure can provide green, environmentally friendly technology because some aspects involve primarily naturally occurring materials (silk and microalgae) that are processed (printing, gelation) in a safe, aqueous, room temperature process. Moreover, silk hydrogel materials can be degraded by proteases, such as protease XIV and proteinase K, and the end products are low molecular weight peptides. This enables the articles of the present disclosure to be disintegrated and recycled for other uses, such as composting and generating biofuels after they complete their tasks. For indoor CO2 reduction applications, safety is a top concern. In some aspects, the articles described herein do not involve any toxic chemicals. In such aspects, all materials may be both bio-compatible and edible.
The methods, articles, and systems of the present disclosure may incorporate 3D printing techniques to allow for easy fabrication of the articles into various forms. In some aspects, the unique combination of silk fibroin and hydroxypropyl methylcellulose allows for an ink solution with improved 3D printing results when compared to prior silk fibroin printing compositions. With regard to microalgae encapsulation in particular, the addition of hydroxypropyl methylcellulose as a thickening agent increases the viscosity of silk fibroin solution without compromising the cell-compatibility and bio-inertness of the resulting silk article. The increased viscosity allows for improved the 3D printing results, because the silk/HPMC ink is able to maintain its 3D shapes after being printed in aqueous solution. Gelatin, agar and alginate have been added in silk solution or other biological inks to achieve similar viscosity-increase effects. However, some of these materials require elevated temperature to melt (e.g. gelatin, agar), which may adversely affect the stability of silk fibroin solutions. Other materials are either difficult to dissolve in silk solution or are ionized in aqueous solution (e.g. alginate). The presence of high ion concentration in silk solution lowers the crosslinking efficiency. For the systems and methods described herein, HPMC presents significant advantages over the existing thickening agents, because 1) it dissolves at room temperature; 2) it mixes easily with silk solution; 3) it does not ionize in aqueous solution; and 4) it does not significantly interfere with the gelation of silk fibroin.
The first step 102 may include first forming a silk fibroin solution, which is then mixed with pre-cultivated microalgae. Alternatively or additionally, the first step may include loading a prepared silk fibroin solution into a device capable of enacting the second step. For instance, the first step may include loading an already prepared silk-fibroin solution into a 3D printing device. Likewise, preparing the silk fibroin solution may involve drawing an already prepared silk fibroin solution into a syringe or a similar device. Preparing the silk fibroin solution may involve applying one or more external stimuli or agents to an already prepared mixture of silk fibroin and microalgae. For instance, the first step 102 may include oxygenating a silk fibroin mixture over an extended period of time to induce microalgae proliferation prior to the second step.
As used herein, the term “silk fibroin” refers to silk fibroin protein whether produced by silkworm, spider, or other insect, or otherwise generated (Lucas et al., Adv. Protein Chem., 13: 107-242 (1958)). Any type of silk fibroin can be used in different embodiments described herein. Silk is naturally produced by various species, including, without limitation: Antheraea mylitta; Antheraea pernyi; Antheraea yamamai; Galleria mellonella; Bombyx mori; Bombyx mandarina; Galleria mellonella; Nephila clavipes; Nephila senegalensis; Gasteracantha mammosa; Argiope aurantia; Araneus diadematus; Latrodectus geometricus; Araneus bicentenarius; Tetragnatha versicolor; Araneus ventricosus; Dolomedes tenebrosus; Euagrus chisoseus; Plectreurys tristis; Argiope trifasciata; and Nephila madagascariensis. Silk fibroin produced by silkworms, such as Bombyx mori, is the most common and represents an earth-friendly, renewable resource. For instance, silk fibroin used in a silk film may be attained by extracting sericin from the cocoons of B. mori. Organic silkworm cocoons are also commercially available. There are many different silks, however, including spider silk (e.g., obtained from Nephila clavipes), transgenic silks, genetically engineered silks, such as silks from bacteria, yeast, mammalian cells, transgenic animals, or transgenic plants, and variants thereof, that can be used. See, e.g., WO 97/08315 and U.S. Pat. No. 5,245,012, each of which is incorporated herein as reference in its entirety.
Thus, in some embodiments, a silk solution is used to fabricate compositions of the present invention contain fibroin proteins, essentially free of sericins. In some embodiments, silk solutions used to fabricate various compositions of the present invention contain the heavy chain of fibroin, but are essentially free of other proteins. In other embodiments, silk solutions used to fabricate various compositions of the present invention contain both the heavy and light chains of fibroin, but are essentially free of other proteins.
Referring back to
Once introduced into the solvent bath, the silk fibroin solution may undergo hydrogelation in the solvent bath. To allow for this hydrogelation to occur, the method may include additional steps of incubating silk fibroin solution in the solvent bath for a period of time to undergo hydrogelation, and then removing the resulting silk article from the solvent bath. Once removed, the method may further comprise a step of placing the silk article in a medium that is suitable for microalgae proliferation. For instance, the resulting silk article may be removed and placed in a solution with a composition resembling seawater. Following introduction into the solvent bath and subsequent hydrogelation, the microalgae may be encapsulated within the resulting silk article.
The silk fibroin solution of the systems and methods of the present disclosure may comprise a chemical composition to support microalgae proliferation and sustained photosynthesis. The silk fibroin concentration in the silk fibroin solution may be from 10 wt % to 40 wt %, based on the total weight of the silk fibroin solution. In some embodiments, the silk fibroin concentration in the silk fibroin solution is at least 10 wt %, or at least 11 wt %, or at least 12 wt %, or at least 13 wt %, or at least 14 wt %, and at most 40 wt %, 30 wt %, 20 wt %, or about 15 wt %.
The microalgae may be a green algae. The microalgae may be of the Platymonas genus. In order to facilitate crosslinking and gelation upon contact with the solvent bath, the silk fibroin solution may comprise horseradish peroxidase. The concentration of horseradish peroxidase in the solution may be from 60 units/ml to 180 units/ml. In some embodiments, the horseradish peroxidase is present at a concentration of at least 60 units/ml, or at least 80 units/ml, or at least 100 units/ml, or at least 120 units/ml, or at most 140 units/ml, or at most 160 units/ml, or at most 180 units/ml. In some embodiments, the silk fibroin solution and the resulting silk article may comprise only nontoxic materials. The silk fibroin solution and the resulting silk article may be biodegradable. The silk fibroin solution and the resulting silk article may be safe for human consumption.
The silk fibroin solution may further comprise a thickening agent to allow the silk fibroin solution to have suitable properties to facilitate proper introduction into the solvent bath. The silk fibroin solution may have a thickening agent to support 3D printing of the solution into the solvent bath. The weight ratio between the silk fibroin to the thickening agent in the silk fibroin solution may range from 3:7 to 6:4, from 4:6 to 6:4, or specifically about 6:4. The concentration of the thickening agent in the silk fibroin solution may be from 10% w/v to 20% w/v, based on the total volume of the silk fibroin solution. The thickening agent may be include viscoelastic polymers including, but not limited to, hydroxypropyl methylcellulose.
The crosslinking agent within the solvent bath may be hydrogen peroxide. The total hydrogen peroxide concentration of the solvent bath may be at least 0.001% w/w, at least 0.05% w/w, at most 0.1% w/w, at most 0.05% w/w, or about 0.01% w/w. The solvent bath may have a chemical composition capable of supporting sustained proliferation of the microalgae. For instance, the solvent bath may comprise one or more salts, such as sodium chloride, in order to support marine microalgae strains. The solvent bath of the systems and methods of the present disclosure may specifically be absent of a photo-crosslinking agent or an organic solvent. For instance, the solvent bath may not comprise or may be substantially free of methanol, ethanol, isopropanol, butanol, ethylene glycol, propylene glycol, glycerol, and acetone.
Optical transparency and stiffness are important properties for evaluating the efficacy of any microalgae encapsulation article. The silk fibroin solution may be introduced into the chemical bath in a manner and have a chemical composition that produces a silk article that has a Young's modulus of at least 1 kPa, a Young's modulus of at least 10 kPa, a Young's modulus of at most 100 kPa, or a Young's modulus of at most 25 kPa. Likewise, the silk fibroin solution may be introduced into the chemical bath in a manner and have a chemical composition that produces a silk article that has a transmittance of at least 50%, at least 60%, or at least 70% over the visible range. Specifically, the optical transparency of the resulting silk article may have a transmittance of higher than 50%, 55%, 60%, 65%, 70%, or 80% at the absorbance peaks for chlorophyll A and B, the major chlorophylls in microalgae.
The resulting silk article of the method 100 may be capable of generating oxygen through photosynthesis of the microalgae. The silk article may be capable of generating oxygen through photosynthesis of the microalgae for at least 10, 30, 50, 70, 90, or 120 days. The resulting silk article may be characterized as supporting the survival of at least 50% of the total initial encapsulated microalgae population for at least 10, 30, 50, 70, 90, or 120 days.
The first step 202 may include first forming a silk fibroin solution, which is then mixed with hydroxypropyl methylcellulose and horseradish peroxidase. Alternatively or additionally, the first step may include loading a prepared silk fibroin solution into a device capable of enacting the second step. For instance, the first step may include loading an already prepared silk-fibroin solution into a 3D printing device. Likewise, preparing the silk fibroin solution may involve drawing an already prepared silk fibroin solution into a syringe or a similar device. Preparing the silk fibroin solution may involve applying one or more external stimuli or agents to an already prepared mixture of silk fibroin and hydroxypropyl methylcellulose.
The second step 204 may include injecting the silk fibroin solution into the solvent bath in a manner that forms a predetermined three-dimensional shape. For instance, the prepared silk fibroin solution may be 3D printed into the solvent bath in a controlled manner. It should be recognized that numerous 3D printing systems and techniques can be applied to introduce the silk fibroin solution into the solvent bath. For instance, the silk fibroin solution may be iteratively layered to form a silk article having a predetermined structure. A desired structure may be specified to any 3D printing system in advance in order to tailor the form of the resulting silk article to the intended application.
Once introduced into the solvent bath through step 204, the silk fibroin solution may undergo hydrogelation in the solvent bath. To allow for this hydrogelation to occur, the method may include additional steps of incubating silk fibroin solution in the solvent bath for a period of time to undergo hydrogelation, and then removing the resulting silk article from the solvent bath.
The silk fibroin concentration in the silk fibroin solution of the method 200 may be from 10 wt % to 40 wt %, based on the total weight of the silk fibroin solution. In some embodiments, the silk fibroin concentration in the silk fibroin solution is at least 10 wt %, or at least 11 wt %, or at least 12 wt %, or at least 13 wt %, or at least 14 wt %, and at most 40 wt %, 30 wt %, 20 wt %, or about 15 wt %.
In some embodiments, the microalgae may be a green algae. The microalgae may be of the Platymonas genus. The concentration of horseradish peroxidase in the solution may be from 60 units/ml to 180 units/ml. In some embodiments, the horseradish peroxidase is present at a concentration of at least 60 units/ml, or at least 80 units/ml, or at least 100 units/ml, or at least 120 units/ml, or at most 140 units/ml, or at most 160 units/ml, or at most 180 units/ml. In some embodiments, the silk fibroin solution and the resulting silk article may comprise only nontoxic materials. The silk fibroin solution and the resulting silk article may be biodegradable. The silk fibroin solution and the resulting silk article may be safe for human consumption.
The weight ratio between the silk fibroin to hydroxypropyl methylcellulose in the silk fibroin solution may range from 3:7 to 6:4, from 4:6 to 6:4, or specifically about 6:4. The concentration of the hydroxypropyl methylcellulose in the silk fibroin solution may range from 10% w/v to 20% w/v.
The total hydrogen peroxide concentration of the solvent bath may be at least 0.001% w/w, at least 0.05% w/w, at most 0.1% w/w, at most 0.05% w/w, or about 0.01% w/w. The solvent bath of the systems and methods of the present disclosure may specifically be absent of a photo-crosslinking agent or an organic solvent.
In one aspect, the present disclosure provides a silk article formed by any of the methods described herein.
The silk article 300 may comprise a chemical composition to support microalgae proliferation and sustained photosynthesis. The silk fibroin concentration in the silk fibroin article may be from 10 wt % to 40 wt %, based on the total weight of the silk fibroin solution. In some embodiments, the silk fibroin concentration in the silk fibroin solution is at least 10 wt %, or at least 11 wt %, or at least 12 wt %, or at least 13 wt %, or at least 14 wt %, and at most 40 wt %, at most 30 wt %, or at most 20 wt %, or about 15 wt %.
In some embodiments, the microalgae may be a green algae. The microalgae may be of the Platymonas genus. The silk article 300 may comprise horseradish peroxidase. The concentration of horseradish peroxidase in the solution may be from 60 units/ml to 180 units/ml. In some embodiments, the horseradish peroxidase is present at a concentration of at least 60 units/ml, or at least 80 units/ml, or at least 100 units/ml, or at least 120 units/ml, or at most 140 units/ml, or at most 160 units/ml, or at most 180 units/ml. In some embodiments, the silk article may comprise only nontoxic materials. The silk article 300 may be biodegradable. The silk article 300 may be safe for human consumption.
The silk article 300 may further comprise a thickening agent. The weight ratio between the silk fibroin to the thickening agent in the silk fibroin solution may range from 3:7 to 6:4, from 4:6 to 6:4, or specifically about 6:4. The concentration of the thickening agent in the silk article 300 may be from 10% w/v to 20% w/v, based on the total volume of the silk fibroin solution. The thickening agent may be include viscoelastic polymers including, but not limited to, hydroxypropyl methylcellulose.
The silk article 300 may have a Young's modulus of at least 1 kPa, a Young's modulus of at least 10 kPa, of a Young's modulus of at most 100 kPa, or a Young's modulus of at most 25 kPa. The silk article 300 may have a transmittance of at least 50%, at least 60%, or at least 70% over the visible range. Specifically, the optical transparency of the silk article 300 may have a transmittance of higher than 50%, 55%, 60%, 65%, 70%, or 80% at the absorbance peaks for chlorophyll A and B, the major chlorophylls in microalgae.
The silk article 300 may be capable of generating oxygen through photosynthesis of the microalgae. The silk article 300 may be capable of generating oxygen through photosynthesis of the microalgae for at least 10, 30, 50, 70, 90, or 120 days. The silk article 300 may be characterized as supporting the survival of at least 50% of the total initial encapsulated microalgae population for at least 10, 30, 50, 70, 90, or 120 days.
In another aspect, the present disclosure provides a silk article comprising silk fibroin, hydroxypropyl methylcellulose, and horseradish peroxidase. The silk fibroin concentration in the silk fibroin article may be from 10% w/v to 40% w/v, from 10% w/v to 20% w/v, or specifically about 15% w/v. The concentration of horseradish peroxidase may be from 60 units/ml to 180 units/ml. The weight ratio between silk fibroin and hydroxypropyl methylcellulose in the silk fibroin article may be from 3:7 to 6:4, from 4:6 to 6:4, or specifically about 6:4. The concentration of the thickening agent in the silk article may be from 10% w/v to 20% w/v. The thickening agent may be hydroxypropyl methylcellulose.
The injector 408 may be configured to introduce the silk fibroin solution 404 into the solvent bath 406 in a manner that forms a predetermined three-dimensional shape. For instance, the injector 408 may be a 3D printer and the prepared silk fibroin solution 404 may be 3D printed into the solvent bath 406 in a controlled manner. It should be recognized that numerous 3D printing systems and techniques can be applied by the injector 408 to introduce the silk fibroin solution 404 into the solvent bath 406. For instance, the silk fibroin solution 404 may be iteratively layered to form a silk article 402 having a predetermined structure. A desired structure may be specified to the injector 408 in advance in order to tailor the form of the resulting silk article 402 to the intended application.
The solvent bath 406 may be configured to incubate the silk fibroin solution for a period of time to undergo hydrogelation and allow for the easy removal the resulting silk article 402 from the solvent bath 406. The silk fibroin solution 404 of the system 400 may comprise a chemical composition to support microalgae proliferation and sustained photosynthesis. The silk fibroin concentration in the silk fibroin solution 404 may be from 10 wt % to 40 wt %, based on the total weight of the silk fibroin solution. In some embodiments, the silk fibroin concentration in the silk fibroin solution is at least 10 wt %, or at least 11 wt %, or at least 12 wt %, or at least 13 wt %, or at least 14 wt %, and at most 40 wt %, at most 30 wt %, at most 20 wt %, or about 15 wt %.
In some embodiments, the microalgae may be a green algae. The microalgae may be of the Platymonas genus. In order to facilitate crosslinking and gelation upon contact with the solvent bath 406, the silk fibroin solution 404 may comprise horseradish peroxidase. The concentration of horseradish peroxidase in the solution may be from 60 units/ml to 180 units/ml. In some embodiments, the horseradish peroxidase is present at a concentration of at least 60 units/ml, or at least 80 units/ml, or at least 100 units/ml, or at least 120 units/ml, or at most 140 units/ml, or at most 160 units/ml, or at most 180 units/ml. The silk fibroin solution 404 may further comprise a thickening agent to allow the silk fibroin solution to have suitable properties to facilitate proper introduction into the solvent bath. The silk fibroin solution may have a thickening agent to support 3D printing of the solution by the injector 408. The weight ratio between the silk fibroin to the thickening agent in the silk fibroin solution may range from 3:7 to 6:4, from 4:6 to 6:4, or specifically about 6:4. The concentration of the thickening agent in the silk fibroin solution may be from 10% w/v to 20% w/v, based on the total volume of the silk fibroin solution. The thickening agent may be include viscoelastic polymers including, but not limited to, hydroxypropyl methylcellulose.
The crosslinking agent within the solvent bath 406 may be hydrogen peroxide. The total hydrogen peroxide concentration of the solvent bath may be between 0.001% w/w and 0.1% w/w, or specifically about 0.01% w/w. The solvent bath may have a chemical composition capable of supporting sustained proliferation of the microalgae. For instance, the solvent bath may comprise one or more salts, such as sodium chloride, in order to support marine microalgae strains. The solvent bath of the systems and methods of the present disclosure may specifically be absent of a photo-crosslinking agent or an organic solvent.
The injector outlet 410 may be a nozzle having a nozzle diameter of about 0.3, 0.4, 0.5, 0.6, or 0.7 mm. The injector may be configured to provide a constant pressure to the silk fibroin solution when introducing the silk fibroin solution into the solvent bath.
The following examples set forth, in detail, ways in which articles containing microalgae and silk fibroin may be produced and utilized, and will enable one of skill in the art to more readily understand the principles thereof. The following examples are presented by way of illustration and are not meant to be limiting in any way.
A Inkredible™ 3D bioprinter (Cellink, Boston, Mass.) was used to print microalgae/silk solutions. The Inkredible™ bioprinter uses stable air pressure to extrude solution out of nozzle, which can allow for more constant solution flow and thus better consistency in printing quality. To prepare microalgae/silk solutions (i.e. the precursor of microalgal silk hydrogels), microalgae were harvested and concentrated at 1,200 rpm for 5 minutes. The concentrated microalgae solution was then mixed with the 26% w/v silk fibroin solution at 2:3 volume ratio, so the final silk concentration was 15.6% w/v. For solution mixtures that did not contain microalgae, only microalgal medium was added at this step. The microalgae/silk mixtures were then mixed with 15% w/v hydroxypropyl methylcellulose (HPMC) solution at various weight ratios (3:7, 4:6, 5:5 and 6:4, which are referred to as silk to HPMC ratio later) to increase the viscosity of the solution mixture to facilitate 3D printing. Finally, HRP was added to the solution mixture at different final concentrations (60, 120 and 180 unit/ml). The solution mixtures were then loaded in syringes that were specifically designed to work with the Inkredible™ bioprinters. The solution-loaded syringes were centrifuged at 2,000 rpm for 3 minutes to remove any air bubbles generated during the mixing of the solution. 3D models were designed with 3ds MAX (Autodesk, San Rafael, Calif., USA). The models were sliced and translated to G-code using Repetier-Host (Hot-World GmbH & Co. KG, Germany). A 0.5 mm layer height and 0.5 mm nozzle diameter were used for the printing. Blunt needles were used as printing nozzles. The air pressure for 3D printing was adjusted based on the viscosity of solution mixture to maintain proper solution flow so the thickness of each layer equaled the layer height (i.e., 0.5 mm). The solution was extruded into a medium (DI water for solution without microalgae, or microalgal medium for solution with microalgae) containing 0.01% w/w H2O2 to initiate crosslinking immediately after printing. This concentration of H2O2 was selected to allow efficient crosslinking to form the gels, while maintaining high cell survival. After the microalgal silk hydrogel was sufficiently crosslinked, the H2O2 containing medium was replaced with microalgal medium to support cell proliferation.
Materials
A marine microalgae strain, Platymonas sp. was used for the study. Platymonas is a microalgal strain that has been utilized in prior photosynthesis-related studies. The microalgae and its medium (Alga-Gro seawater medium) were obtained from Carolina Biological Supply Company (Burlington, N.C., USA). Raw silk cocoons produced by Bombyx mori silkworms were obtained from Tajima Shoji Co (Yokohama, Japan). Sodium carbonate, lithium bromide (LiBr), horseradish peroxidase (HRP), hydrogen peroxide (H2O2) and hydroxypropyl methylcellulose (HPMC) were purchased from Sigma-Aldrich (St. Louis, Mo., USA). Dialysis cassettes was purchased from Fisher Scientific (Pittsburgh, Pa., USA). 3D printing syringes were purchased from Nordson Medical (Marlborough, Mass., USA). Blunt needles were purchased from McMaster-Carr (Robbinsville, N.J., USA). Food coloring was obtained from a local grocery store.
Silk Processing
To prepare the silk fibroin solution, silk cocoons were diced into 1 cm2 pieces. The cocoon pieces were then degummed by boiling in 0.2% w/w sodium carbonate solution for 30 min in order to remove the sericin. The degummed silk fibers were rinsed in copious amounts of water and allowed to dry for at least 12 hours. 9.3M LiBr solution was then used to dissolve silk fiber into fibroin solution at 60° C. for 4 hours. The silk fibroin solution was dialyzed against deionized (DI) water in dialysis cassettes with a 3,500 molecular weight cutoff for three days with at least 6 water changes to completely remove the LiBr content. Finally, the fibroin solution was centrifuged at 9,000 rpm at 4° C. for 20 min twice and filtered through a filter with 5 μm pore size to remove undissolved residues. The resulting solution contained only silk fibroin at 6% w/v and water. The silk fibroin solution was concentrated in dialysis cassettes in a fume hood to reach a concentration of 26% w/v, which was used later to prepare microalgae/silk mixtures for the hydrogel 3D printing.
Microalgae Culture
Microalgae were cultured according to the protocol recommended by the manufacturer. In brief, Platymonas sp. was cultured in suspension in sterile Erlenmeyer flasks at room temperature. Cool-white fluorescent lights at 2152 to 4304 lux were used for the initial 7 to 10 days to allow microalgae to grow. Light intensity was then lowered to 538 to 1076 lux to slow the growth for storage. A 16-hour light: 8-hour dark cycle was used. Constant air bubbling with air stone was used to supply oxygen to the medium to keep the oxygen concentration at 8.9 mg/L (100%). Microalgae concentration was calculated using a hemocytometer at the time of harvesting.
Characterization of 3D Printed Silk Hydrogel Materials
Ink mixtures at different silk to HPMC ratios were evaluated by rheometry (TA instruments) to characterize the dynamic viscosity. Solution mixtures were challenged with a range of shear rates from 0.001 s−1 to 1000 s−1, and shear stress was used to calculate the viscosity. HRP with different final concentrations (60, 120 and 180 units/ml) was added to these solution mixtures, which were 3D printed in 0.01% H2O2 solution into a disc shape with 1.35 cm diameter and 2 mm height. The hydrogel discs were fully crosslinked overnight in H2O2 solution before they were tested for Young's modulus by Instron (model 3366, Norwood, Mass., USA). Mechanical compression and 40% maximum strain were used in these evaluations. Young's modulus was calculated at 20% strain. To characterize gelation kinetics of printed solutions, solution mixtures were 3D printed in black 96 well plate in H2O2 solution Immediately after printing, the intrinsic fluorescence of crosslinked phenolic groups at 415 nm was measured using a 315 nm excitation wavelength until a plateau was reached. The fraction of the maximum intensity, after subtracting background with H2O2, is reported as the degree of gelation. To measure the optical transparency of the printed structure, solution mixtures with 180 unit/ml HRP were printed into a disc shape with 2 cm diameter and 0.5 mm height in H2O2 solution and allowed to crosslink overnight. The optical absorbance was then measured from 350 nm to 750 nm, at 50 nm intervals, using a plate reader (SpectraMax M2, Molecular Devices). For all hydrogel materials characterization mentioned above, microalgae were not added.
Characterization of Microalgae Proliferation and Photosynthesis in 3D Printed Hydrogel Structures
All microalgal silk hydrogel structures were printed using a solution mixture with 6:4 silk to HPMC ratio and 180 unit/ml HRP concentration. This formula was selected due to optimal solution viscosity, gelation speed, mechanical stiffness and optical transparency. For microalgal proliferation evaluations, a 0.5 mm thick gel was printed in each well of a 24-well plate. The initial microalgal concentration was 7.5×106 cells per milliliter of hydrogel. This low initial concentration was selected to allow room for microalgal proliferation and to facilitate easier cell counting. The microalgal silk hydrogels were then imaged using phase-contrast bright-field microscopy at days 0, 2, 6, 10, 17 and 30, and all cells that were in focus were counted to quantitatively calculate algal proliferation rate. The proliferation rate is presented as average daily increase of cell number (%),calculated by averaging the percent increase of cell numbers since the prior observation over the number of days since the prior observation. To characterize the photosynthesis of microalgal silk structures, microalgal hydrogel sheets of 5 cm wide, 10 cm long and 2 mm thick were printed and transferred to a BOD bottle. The initial microalgal concentration in these sheets was 5×107 cells per milliliter of hydrogel. Then 30 ml microalgal medium was added in each bottle and the change in oxygen level was measured every 3 days using a needle-type optical oxygen sensor and a Microx 4 meter (both from PreSens, Germany). After each measurement, the medium was replaced. The oxygen concentration was reported as mg/L.
Statistics
Young's modulus of hydrogels, microalgal proliferation rate and oxygen production of microalgal silk structures were tested in duplicates and the data were presented as mean with standard deviation (+/−SD).
Results and Discussion
When choosing a thickening agent for silk hydrogel printing, the following criteria were considered: 1) room-temperature solubility; 2) easy dissolution in silk fibroin solution; and 3) absence of ionization in aqueous solution. Based on these criteria, hydroxypropyl methylcellulose (HPMC) was selected, which is chemically inert and biocompatible. We tested the dynamic viscosity of solution mixtures at several different silk to HPMC ratios (
Next, we studied the gelation kinetics of the solution mixtures with different silk to HPMC ratios and HRP concentrations. It was suspected that there might be a positive correlation between silk fibroin gelation rate and HRP concentration, however the impact of HPMC content on the reaction kinetics was not clear. By examining the formation of phenolic crosslinking, with intrinsic fluorescence at 415 nm when excited at 315 nm, the gelation kinetics were quantified (
The addition of HPMC also influenced the Young's modulus of the hydrogel (
For microalgae immobilization, optical transparency is a key characteristic of the hydrogel material, as it directly affects light transmission and photosynthetic efficiency. Solution mixtures with different silk to HPMC ratios were printed in H2O2 solution and allowed to fully crosslink overnight. As can be seen in
All solution mixtures formulated were tested for printability (
As a signature advantage of this new system, the silk hydrogel is able to provide a cell-friendly matrix that allows 3D encapsulation while maintaining normal cell proliferation and functions. Here, we wanted to determine whether the silk hydrogels could also support long-term 3D cultures of the microalgae and maintain photosynthetic activity. We added microalgae in the silk/HPMC solution mixture with a 6:4 silk to HPMC ratio right before printing. After the printed structures were completely crosslinked, the H2O2 containing medium was replaced with fresh microalgal medium to support the survival and proliferation of the microalgae. Microalgal proliferation was determined by counting cell number increases under phase contrast microscopy for four weeks post printing (
However, the cells were able to divide and maintained their normal elliptical shape of 3 to 4 μm in length and 2 to 3 μm in width (
Using a non-invasive optical sensor, the photosynthetic activity of the 3D printed microalgal silk hydrogel structures was determined. The microalgal silk structures were immersed in microalgal medium, which was changed every three days and the oxygen concentration was measured before and after each medium change for 90 days. The test was conducted in BOD bottles with water seals to prevent gas exchange with the outside environment (
One advantage of our system is that it is a green, environmentally friendly technology because it only involves naturally occurring materials (silk and microalgae) that are processed (printing, gelation) in a safe, aqueous, room temperature process. Moreover, silk hydrogel materials can be degraded by proteases, such as protease XIV and proteinase K, and the end products are low molecular weight peptides. This enables our systems to be disintegrated and recycled for other uses, such as composting and generating biofuels after they complete their tasks. For indoor applications, safety is a top concern. As aforementioned, our systems do not involve any toxic chemicals. All materials are both bio-compatible and even edible; there are numerous consumer products sold that are ingested or applied to the body. Silk has also been used to coat perishable food to extend shelf life, and is used in medical products as degradable systems. The consumption of microalgae as food and supplement also has a long history. Taken together, these unique advantages make our systems suitable for indoor and home utilities.
In conclusion, a microalgae/silk solution with mechanical properties and gelation kinetics useful for 3D printing was developed and successfully utilized to host microalgae in this experiment. The silk hydrogels provided a host environment to support the long-term proliferation and photosynthetic activity of encapsulated microalgae. Microalgae proliferation was demonstrated for more than 4 weeks and stable photosynthetic activity was observed for at least 90 days. The printability, stability and long-term functionality of such material supports potential environmental utilities.
It is contemplated that incorporating the silk articles of the present disclosure into residential items capable of active removal of CO2 from the environment.
The present disclosure has been described one or more embodiments, and it should be appreciated that many equivalents, alternatives, variations, and modifications, aside from those expressly stated, are possible and within the scope of the invention.
This application is based on, claims priority to, and incorporates herein by reference in its entirety, U.S. Provisional Patent Application Ser. No. 62/840,295, filed on Apr. 29, 2019 and entitled “System and Method for Living Silk Articles”.
This invention was made with government support under grant P41 EB002520 awarded by the National Institutes of Health. The government has certain rights in the invention.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2020/030570 | 4/29/2020 | WO | 00 |
Number | Date | Country | |
---|---|---|---|
62840295 | Apr 2019 | US |